288 related articles for article (PubMed ID: 27223283)
1. Prodrug Strategies for Paclitaxel.
Meng Z; Lv Q; Lu J; Yao H; Lv X; Jiang F; Lu A; Zhang G
Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27223283
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, and evaluation of water-soluble morpholino-decorated paclitaxel prodrugs with remarkably decreased toxicity.
Feng S; Chen K; Wang C; Jiang X; Dong H; Gong Z; Liu K
Bioorg Med Chem Lett; 2016 Aug; 26(15):3598-602. PubMed ID: 27311893
[TBL] [Abstract][Full Text] [Related]
3. Fluorinated paclitaxel prodrugs for potentiated stability and chemotherapy.
Jiang B; Hao D; Li C; Lu S; Pei Q; Xie Z
J Mater Chem B; 2021 Dec; 9(48):9971-9979. PubMed ID: 34871339
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of taxoids 5. Synthesis and evaluation of novel water-soluble prodrugs of a 3'-desphenyl-3'-cyclopropyl analogue of docetaxel.
Yamaguchi T; Harada N; Ozaki K; Arakawa H; Oda K; Nakanishi N; Tsujihara K; Hashiyama T
Bioorg Med Chem Lett; 1999 Jun; 9(12):1639-44. PubMed ID: 10397492
[TBL] [Abstract][Full Text] [Related]
5. Paclitaxel esters of malic acid as prodrugs with improved water solubility.
Damen EW; Wiegerinck PH; Braamer L; Sperling D; de Vos D; Scheeren HW
Bioorg Med Chem; 2000 Feb; 8(2):427-32. PubMed ID: 10722165
[TBL] [Abstract][Full Text] [Related]
6. Fine-Tuning the Linear Release Rate of Paclitaxel-Bearing Supramolecular Filament Hydrogels through Molecular Engineering.
Chakroun RW; Wang F; Lin R; Wang Y; Su H; Pompa D; Cui H
ACS Nano; 2019 Jul; 13(7):7780-7790. PubMed ID: 31117370
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of water-soluble paclitaxel prodrugs.
Feng X; Yuan YJ; Wu JC
Bioorg Med Chem Lett; 2002 Nov; 12(22):3301-3. PubMed ID: 12392737
[TBL] [Abstract][Full Text] [Related]
8. Balancing the efficacy vs. the toxicity of promiscuous natural products: Paclitaxel-based acid-labile lipophilic prodrugs as promising chemotherapeutics.
Haider S; Penfornis P; Claudio PP; McChesney JD; Chittiboyina AG
Eur J Med Chem; 2022 Jan; 227():113891. PubMed ID: 34656042
[TBL] [Abstract][Full Text] [Related]
9. Exquisite Vesicular Nanomedicine by Paclitaxel Mediated Co-assembly with Camptothecin Prodrug.
Zhou Z; Du C; Zhang Q; Yu G; Zhang F; Chen X
Angew Chem Int Ed Engl; 2021 Sep; 60(38):21033-21039. PubMed ID: 34278702
[TBL] [Abstract][Full Text] [Related]
10. Well-Defined Redox-Sensitive Polyethene Glycol-Paclitaxel Prodrug Conjugate for Tumor-Specific Delivery of Paclitaxel Using Octreotide for Tumor Targeting.
Yin T; Wu Q; Wang L; Yin L; Zhou J; Huo M
Mol Pharm; 2015 Aug; 12(8):3020-31. PubMed ID: 26086430
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of 2'-carbamate-linked and 2'-carbonate-linked prodrugs of paclitaxel: selective activation by the tumor-associated protease plasmin.
de Groot FM; van Berkom LW; Scheeren HW
J Med Chem; 2000 Aug; 43(16):3093-102. PubMed ID: 10956217
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of 2'-paclitaxel 2-deoxy-2-fluoro-glucopyranosyl carbonate for specific targeted delivery to cancer cells.
Meng X; Lian X; Li X; Ya Q; Li T; Zhang Y; Yang Y; Zhang Y
Carbohydr Res; 2020 Jul; 493():108034. PubMed ID: 32485481
[TBL] [Abstract][Full Text] [Related]
13. Acetal-linked paclitaxel prodrug micellar nanoparticles as a versatile and potent platform for cancer therapy.
Gu Y; Zhong Y; Meng F; Cheng R; Deng C; Zhong Z
Biomacromolecules; 2013 Aug; 14(8):2772-80. PubMed ID: 23777504
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological activity of beta-glucuronyl carbamate-based prodrugs of paclitaxel as potential candidates for ADEPT.
de Bont DB; Leenders RG; Haisma HJ; van der Meulen-Muileman I; Scheeren HW
Bioorg Med Chem; 1997 Feb; 5(2):405-14. PubMed ID: 9061205
[TBL] [Abstract][Full Text] [Related]
15. Nanoprodrug of retinoic acid-modified paclitaxel.
Zhou Z; Yan J; Sun T; Wang X; Xie Z
Org Biomol Chem; 2017 Nov; 15(45):9611-9615. PubMed ID: 29106434
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, Biological Evaluation and Low-Toxic Formulation Development of Glycosylated Paclitaxel Prodrugs.
Mao Y; Zhang Y; Luo Z; Zhan R; Xu H; Chen W; Huang H
Molecules; 2018 Dec; 23(12):. PubMed ID: 30563132
[TBL] [Abstract][Full Text] [Related]
17. New Taxol (paclitaxel) prodrugs designed for ADEPT and PMT strategies in cancer chemotherapy.
Alaoui AE; Saha N; Schmidt F; Monneret C; Florent JC
Bioorg Med Chem; 2006 Jul; 14(14):5012-9. PubMed ID: 16554162
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and anti-cancer efficacy of rapid hydrolysed water-soluble paclitaxel pro-drugs.
Ryu BY; Sohn JS; Hess M; Choi SK; Choi JK; Jo BW
J Biomater Sci Polym Ed; 2008; 19(3):311-24. PubMed ID: 18325233
[TBL] [Abstract][Full Text] [Related]
19. Prodrugs of Pyrazolo[3,4-d]pyrimidines: From Library Synthesis to Evaluation as Potential Anticancer Agents in an Orthotopic Glioblastoma Model.
Vignaroli G; Iovenitti G; Zamperini C; Coniglio F; Calandro P; Molinari A; Fallacara AL; Sartucci A; Calgani A; Colecchia D; Mancini A; Festuccia C; Dreassi E; Valoti M; Musumeci F; Chiariello M; Angelucci A; Botta M; Schenone S
J Med Chem; 2017 Jul; 60(14):6305-6320. PubMed ID: 28650650
[TBL] [Abstract][Full Text] [Related]
20. Nanoparticles Containing High Loads of Paclitaxel-Silicate Prodrugs: Formulation, Drug Release, and Anticancer Efficacy.
Han J; Michel AR; Lee HS; Kalscheuer S; Wohl A; Hoye TR; McCormick AV; Panyam J; Macosko CW
Mol Pharm; 2015 Dec; 12(12):4329-35. PubMed ID: 26505116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
